1 results match your criteria: "Dana-Farber Cancer Institute Boston MA USA lyn_jones@dfci.harvard.edu nowak@crystal.harvard.edu.[Affiliation]"

Many cereblon (CRBN) ligands have been used to develop proteolysis targeting chimeras (PROTACs), but all are reversible binders of the E3 ubiquitin ligase. We recently described the use of sulfonyl exchange chemistry to design binders that covalently engage histidine 353 in CRBN for the first time. Here we show that covalent CRBN ligands can be used to develop efficient PROTAC degraders.

View Article and Find Full Text PDF